Detalhe da pesquisa
1.
Fragmentation landscape of cell-free DNA revealed by deconvolutional analysis of end motifs.
Proc Natl Acad Sci U S A
; 120(17): e2220982120, 2023 04 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-37075072
2.
Preclinical evaluation of the VEGF/Ang2 bispecific nanobody BI 836880 in nasopharyngeal carcinoma models.
Invest New Drugs
; 41(5): 699-709, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37572231
3.
Orientation-aware plasma cell-free DNA fragmentation analysis in open chromatin regions informs tissue of origin.
Genome Res
; 29(3): 418-427, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30808726
4.
Convolutional neural network for discriminating nasopharyngeal carcinoma and benign hyperplasia on MRI.
Eur Radiol
; 31(6): 3856-3863, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-33241522
5.
Sequencing-based counting and size profiling of plasma Epstein-Barr virus DNA enhance population screening of nasopharyngeal carcinoma.
Proc Natl Acad Sci U S A
; 115(22): E5115-E5124, 2018 05 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-29760067
6.
Analysis of Plasma Epstein-Barr Virus DNA to Screen for Nasopharyngeal Cancer.
N Engl J Med
; 377(6): 513-522, 2017 08 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-28792880
7.
The emerging data on choice of optimal therapy for locally advanced nasopharyngeal carcinoma.
Curr Opin Oncol
; 32(3): 187-195, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32175925
8.
Sequencing Analysis of Plasma Epstein-Barr Virus DNA Reveals Nasopharyngeal Carcinoma-Associated Single Nucleotide Variant Profiles.
Clin Chem
; 66(4): 598-605, 2020 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32191318
9.
Distinguishing early-stage nasopharyngeal carcinoma from benign hyperplasia using intravoxel incoherent motion diffusion-weighted MRI.
Eur Radiol
; 29(10): 5627-5634, 2019 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-30903340
10.
Amide proton transfer MRI detects early changes in nasopharyngeal carcinoma: providing a potential imaging marker for treatment response.
Eur Arch Otorhinolaryngol
; 276(2): 505-512, 2019 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-30511106
11.
Association Between Serum Folate Level and Toxicity of Capecitabine During Treatment for Colorectal Cancer.
Oncologist
; 23(12): 1436-1445, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-29802221
12.
Liver- and Colon-Specific DNA Methylation Markers in Plasma for Investigation of Colorectal Cancers with or without Liver Metastases.
Clin Chem
; 64(8): 1239-1249, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29903871
13.
Noninvasive detection of cancer-associated genome-wide hypomethylation and copy number aberrations by plasma DNA bisulfite sequencing.
Proc Natl Acad Sci U S A
; 110(47): 18761-8, 2013 Nov 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-24191000
14.
Clinical utility of plasma Epstein-Barr virus DNA and ERCC1 single nucleotide polymorphism in nasopharyngeal carcinoma.
Cancer
; 121(16): 2720-9, 2015 Aug 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-25946469
15.
Personalizing therapy for colorectal cancer.
Clin Gastroenterol Hepatol
; 12(1): 139-44, 2014 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-24025538
16.
Current advances in targeted therapy for metastatic colorectal cancer - Clinical translation and future directions.
Cancer Treat Rev
; 125: 102700, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38422896
17.
Radiologic extranodal extension for nodal staging in nasopharyngeal carcinoma.
Radiother Oncol
; 191: 110050, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38101457
18.
Early detection of nasopharyngeal carcinoma: performance of a short contrast-free screening magnetic resonance imaging.
J Natl Cancer Inst
; 116(5): 665-672, 2024 May 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38171488
19.
Intermittent versus continuous erlotinib with concomitant modified "XELOX" (q3W) in first-line treatment of metastatic colorectal cancer: correlation with serum amphiregulin and transforming growth factor alpha.
Cancer
; 119(23): 4145-53, 2013 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-24114668
20.
Preclinical evaluation of the PI3K-mTOR dual inhibitor PF-04691502 as a novel therapeutic drug in nasopharyngeal carcinoma.
Invest New Drugs
; 31(6): 1399-408, 2013 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-23975511